Merck Co advanced 4.96% as the best performer on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.from Moneycontrol Global Markets https://ift.tt/HmK9Ga3
via IFTTT
US stocks close with gains, led by Dow as investors look for rate insight
March 27, 2024
0
Merck Co advanced 4.96% as the best performer on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.from Moneycontrol Global Markets https://ift.tt/HmK9Ga3
via IFTTT
